Ajax-Loading

AbbVie Inc - Financial Leverage Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Financial-Leverage-Ratio" stands at 282.50 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Financial Leverage Ratio" stands at 282.50. This represents an increase of 442.25 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1,448.06 percent compared to the value the year prior.
The 1 year change in percent is 1,448.06.
The 3 year change in percent is 2,966.72.

The Serie's long term average value is 34.22. It's latest available value, on 09/30/2025, is 725.59 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +3,100.59%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Financial Leverage Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Financial Leverage Ratio905,699,262,464.00
LogoJohnson & Johnson - Financial Leverage Ratio486,508,953,600.00
LogoRoche Holding AG - Financial Leverage Ratio317,433,206,677.55
LogoAstraZeneca PLC - Financial Leverage Ratio280,205,508,085.11
LogoNovartis AG - Financial Leverage Ratio255,096,620,580.91